Sweegen expands sugar reduction portfolio

image credit- shutterstock

Brazzein fits into consumer diets such as Keto, diabetes, or low-to-no carbohydrate lifestyles

Sweegen, based in the US, is expanding its extensive sweetener portfolio in early 2022 with the zero-calorie, high-intensity sweetener brazzein. 

The product was developed in collaboration with long-term innovation partner Conagen, which has scaled it to commercial production.

Brazzein is a small, heat-stable protein, 500 to 2,000 times sweeter than regular sugar, making it very attractive to food and beverage manufacturers seeking excellent value in a sweetener.

As a sweetener, brazzein promises little to no bitter aftertaste and helps to reduce sweet linger, reducing taste modulation challenges in the natural sweetener space.

Brazzein is stable in a wide range of pH and retains its qualities after pasteurization.  It is also readily soluble, making it ideal for sugar reduction across a spectrum of food and beverage applications.

Found sparingly in nature, brazzein derives from the West African climbing plant’s fruit, oubli. To scale brazzein sustainably, Conagen produces it by a proprietary precision fermentation process, a technology producing clean, nature-based ingredients.

Read Previous

Probiotics as targeted bacteriotherapy: A new frontier

Read Next

MetroMedi.com lays focus on plant-based medicines, health groceries

Leave a Reply